Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Streptavidin-conjugated gold nanoclusters as ultrasensitive fluorescent sensors for early diagnosis of HIV infection.

Kurdekar AD, Avinash Chunduri LA, Manohar CS, Haleyurgirisetty MK, Hewlett IK, Venkataramaniah K.

Sci Adv. 2018 Nov 21;4(11):eaar6280. doi: 10.1126/sciadv.aar6280. eCollection 2018 Nov.

2.

Cross-Subtype Detection of HIV-1 Capsid p24 Antigen Using a Sensitive Europium Nanoparticle Assay.

Haleyur Giri Setty MK, Kurdekar A, Mahtani P, Liu J, Hewlett IK.

AIDS Res Hum Retroviruses. 2019 Apr;35(4):396-401. doi: 10.1089/AID.2018.0163. Epub 2019 Jan 14.

PMID:
30411969
3.

Femtogram Level Sensitivity achieved by Surface Engineered Silica Nanoparticles in the Early Detection of HIV Infection.

Chunduri LAA, Kurdekar A, Haleyurgirisetty MK, Bulagonda EP, Kamisetti V, Hewlett IK.

Sci Rep. 2017 Aug 2;7(1):7149. doi: 10.1038/s41598-017-07299-1.

4.

Novel Time-Resolved Fluorescence Europium Nanoparticle Immunoassay for Detection of Human Immunodeficiency Virus-1 Group O Viruses Using Microplate and Microchip Platforms.

Haleyur Giri Setty MK, Liu J, Mahtani P, Zhang P, Du B, Ragupathy V, Devadas K, Hewlett IK.

AIDS Res Hum Retroviruses. 2016 Jun;32(6):612-9. doi: 10.1089/aid.2014.0351. Epub 2016 Mar 15.

5.

Identification and characterization of a highly pathogenic H5N1 avian influenza A virus during an outbreak in vaccinated chickens in Egypt.

Amen O, Vemula SV, Zhao J, Ibrahim R, Hussein A, Hewlett IK, Moussa S, Mittal SK.

Virus Res. 2015 Dec 2;210:337-43. doi: 10.1016/j.virusres.2015.09.004. Epub 2015 Sep 9.

PMID:
26363196
6.

Genotypic prediction of tropism of highly diverse HIV-1 strains from Cameroon.

Mbondji-Wonje C, Ragupathy V, Zhao J, Nanfack A, Lee S, Torimiro J, Nyambi P, Hewlett IK.

PLoS One. 2014 Nov 7;9(11):e112434. doi: 10.1371/journal.pone.0112434. eCollection 2014.

7.

Development of a microchip Europium nanoparticle immunoassay for sensitive point-of-care HIV detection.

Liu J, Du B, Zhang P, Haleyurgirisetty M, Zhao J, Ragupathy V, Lee S, DeVoe DL, Hewlett IK.

Biosens Bioelectron. 2014 Nov 15;61:177-83. doi: 10.1016/j.bios.2014.04.057. Epub 2014 May 9.

PMID:
24880655
8.

Point of Care Technologies for HIV.

Haleyur Giri Setty MK, Hewlett IK.

AIDS Res Treat. 2014;2014:497046. doi: 10.1155/2014/497046. Epub 2014 Jan 21. Review.

9.

Seroprevalence of human herpesvirus-8 in HIV-1 infected and uninfected individuals in Cameroon.

Mbondji-Wonje C, Ragupathy V, Lee S, Wood O, Awazi B, Hewlett IK.

Viruses. 2013 Sep 19;5(9):2253-9. doi: 10.3390/v5092253.

10.

Testing strategies for detection of xenotropic murine leukemia virus-related virus infection.

Tang S, Hewlett IK.

Adv Virol. 2011;2011:281425. doi: 10.1155/2011/281425. Epub 2011 Jul 28.

11.

Sensitive detection assays for influenza RNA do not reveal viremia in US blood donors.

Stramer SL, Collins C, Nugent T, Wang X, Fuschino M, Heitman JW, Law J, Krysztof DE, Kiely N, Todd D, Vermeulen NM, Harrington K, Kamel H, Kelvin DJ, Busch MP, St George K, Hewlett IK, Linnen JM, Norris PJ; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II).

J Infect Dis. 2012 Mar 15;205(6):886-94. doi: 10.1093/infdis/jir863. Epub 2012 Jan 31.

12.

Absence of detectable XMRV and other MLV-related viruses in healthy blood donors in the United States.

Tang S, Zhao J, Haleyur Giri Setty MK, Devadas K, Gaddam D, Viswanath R, Wood O, Zhang P, Hewlett IK.

PLoS One. 2011;6(11):e27391. doi: 10.1371/journal.pone.0027391. Epub 2011 Nov 14.

13.

Anthrax edema toxin impairs clearance in mice.

Sastalla I, Tang S, Crown D, Liu S, Eckhaus MA, Hewlett IK, Leppla SH, Moayeri M.

Infect Immun. 2012 Feb;80(2):529-38. doi: 10.1128/IAI.05947-11. Epub 2011 Nov 21.

14.

Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study.

Simmons G, Glynn SA, Komaroff AL, Mikovits JA, Tobler LH, Hackett J Jr, Tang N, Switzer WM, Heneine W, Hewlett IK, Zhao J, Lo SC, Alter HJ, Linnen JM, Gao K, Coffin JM, Kearney MF, Ruscetti FW, Pfost MA, Bethel J, Kleinman S, Holmberg JA, Busch MP; Blood XMRV Scientific Research Working Group (SRWG).

Science. 2011 Nov 11;334(6057):814-7. doi: 10.1126/science.1213841. Epub 2011 Sep 22.

15.

Susceptibility of human primary neuronal cells to xenotropic murine leukemia virus-related (XMRV) virus infection.

Ravichandran V, Major EO, Ibe C, Monaco MC, Girisetty MK, Hewlett IK.

Virol J. 2011 Sep 20;8:443. doi: 10.1186/1743-422X-8-443.

16.

XMRV: usage of receptors and potential co-receptors.

Setty MK, Devadas K, Ragupathy V, Ravichandran V, Tang S, Wood O, Gaddam DS, Lee S, Hewlett IK.

Virol J. 2011 Sep 6;8:423. doi: 10.1186/1743-422X-8-423.

17.

The Blood Xenotropic Murine Leukemia Virus-Related Virus Scientific Research Working Group: mission, progress, and plans.

Simmons G, Glynn SA, Holmberg JA, Coffin JM, Hewlett IK, Lo SC, Mikovits JA, Switzer WM, Linnen JM, Busch MP; Blood XMRV Scientific Research Working Group.

Transfusion. 2011 Mar;51(3):643-53. doi: 10.1111/j.1537-2995.2011.03063.x. Epub 2011 Mar 1. No abstract available.

18.

Absence of detectable xenotropic murine leukemia virus-related virus in plasma or peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected blood donors or individuals in Africa.

Tang S, Zhao J, Viswanath R, Nyambi PN, Redd AD, Dastyar A, Spacek LA, Quinn TC, Wang X, Wood O, Gaddam D, Devadas K, Hewlett IK.

Transfusion. 2011 Mar;51(3):463-8. doi: 10.1111/j.1537-2995.2010.02932.x. Epub 2010 Nov 15.

19.

Multiplexed, rapid detection of H5N1 using a PCR-free nanoparticle-based genomic microarray assay.

Zhao J, Tang S, Storhoff J, Marla S, Bao YP, Wang X, Wong EY, Ragupathy V, Ye Z, Hewlett IK.

BMC Biotechnol. 2010 Oct 13;10:74. doi: 10.1186/1472-6750-10-74.

20.

Ultrasensitive detection of HIV-1 p24 antigen using nanofunctionalized surfaces in a capacitive immunosensor.

Teeparuksapun K, Hedström M, Wong EY, Tang S, Hewlett IK, Mattiasson B.

Anal Chem. 2010 Oct 15;82(20):8406-11. doi: 10.1021/ac102144a.

PMID:
20873850
21.

Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection.

Tang S, Zhao J, Wang A, Viswanath R, Harma H, Little RF, Yarchoan R, Stramer SL, Nyambi PN, Lee S, Wood O, Wong EY, Wang X, Hewlett IK.

Clin Vaccine Immunol. 2010 Aug;17(8):1244-51. doi: 10.1128/CVI.00066-10. Epub 2010 Jun 9.

22.

Lipopolysaccharide suppresses HIV-1 replication in human monocytes by protein kinase C-dependent heme oxygenase-1 induction.

Devadas K, Hewlett IK, Dhawan S.

J Leukoc Biol. 2010 May;87(5):915-24. doi: 10.1189/jlb.0307172. Epub 2010 Jan 8.

PMID:
20061555
23.

HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naïve to HAART in Cameroon.

Burda ST, Viswanath R, Zhao J, Kinge T, Anyangwe C, Tinyami ET, Haldar B, Powell RL, Jarido V, Hewlett IK, Nyambi PN.

J Med Virol. 2010 Feb;82(2):187-96. doi: 10.1002/jmv.21677.

24.

Detection of anthrax toxin by an ultrasensitive immunoassay using europium nanoparticles.

Tang S, Moayeri M, Chen Z, Harma H, Zhao J, Hu H, Purcell RH, Leppla SH, Hewlett IK.

Clin Vaccine Immunol. 2009 Mar;16(3):408-13. doi: 10.1128/CVI.00412-08. Epub 2009 Jan 7.

25.

In vitro evaluation of the protective role of human antibodies to West Nile virus (WNV) produced during natural WNV infection.

Rios M, Daniel S, Dayton AI, Wood O, Hewlett IK, Epstein JS, Caglioti S, Stramer SL.

J Infect Dis. 2008 Nov 1;198(9):1300-8. doi: 10.1086/592277.

PMID:
18771407
26.

Nanoparticle-Based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen.

Tang S, Zhao J, Storhoff JJ, Norris PJ, Little RF, Yarchoan R, Stramer SL, Patno T, Domanus M, Dhar A, Mirkin CA, Hewlett IK.

J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):231-7.

PMID:
17693896
27.

West Nile virus adheres to human red blood cells in whole blood.

Rios M, Daniel S, Chancey C, Hewlett IK, Stramer SL.

Clin Infect Dis. 2007 Jul 15;45(2):181-6. Epub 2007 Jun 12.

PMID:
17578776
28.

Antibodies against a multiple-peptide conjugate comprising chemically modified human immunodeficiency virus type-1 functional Tat peptides inhibit infection.

Devadas K, Boykins RA, Hewlett IK, Wood OL, Clouse KA, Yamada KM, Dhawan S.

Peptides. 2007 Mar;28(3):496-504. Epub 2006 Dec 22.

PMID:
17188401
29.

A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein.

Tang S, Ablan S, Dueck M, Ayala-López W, Soto B, Caplan M, Nagashima K, Hewlett IK, Freed EO, Levin JG.

Virology. 2007 Mar 1;359(1):105-15. Epub 2006 Oct 19.

30.
31.

Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion.

Rios M, Zhang MJ, Grinev A, Srinivasan K, Daniel S, Wood O, Hewlett IK, Dayton AI.

Transfusion. 2006 Apr;46(4):659-67.

PMID:
16584445
32.

Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.

Devadas K, Boykins RA, Hardegen NJ, Philp D, Kleinman HK, Osa EO, Wang J, Clouse KA, Wahl LM, Hewlett IK, Rappaport J, Yamada KM, Dhawan S.

Peptides. 2006 Apr;27(4):611-21. Epub 2005 Oct 26.

PMID:
16256245
33.

Seroprevalence of human T cell leukemia virus in HIV antibody-negative populations in rural Cameroon.

Machuca A, Wood O, Lee S, Daniel S, Rios M, Wolfe ND, Carr JK, Eitel MN, Tamoufe U, Torimiro JN, Burke D, Hewlett IK.

Clin Infect Dis. 2005 Jun 1;40(11):1673-6. Epub 2005 Apr 29.

PMID:
15889367
34.

Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003.

Coste J, Reesink HW, Engelfriet CP, Laperche S, Brown S, Busch MP, Cuijpers HT, Elgin R, Ekermo B, Epstein JS, Flesland O, Heier HE, Henn G, Hernandez JM, Hewlett IK, Hyland C, Keller AJ, Krusius T, Levicnik-Stezina S, Levy G, Lin CK, Margaritis AR, Muylle L, Niederhauser C, Pastila S, Pillonel J, Pineau J, van der Poel CL, Politis C, Roth WK, Sauleda S, Seed CR, Sondag-Thull D, Stramer SL, Strong M, Vamvakas EC, Velati C, Vesga MA, Zanetti A.

Vox Sang. 2005 May;88(4):289-303. No abstract available. Erratum in: Vox Sang. 2005 Aug;89(2):119. Neiderhauser, C [corrected to Niederhauser, C].

PMID:
15877653
35.

Mechanisms for macrophage-mediated HIV-1 induction.

Devadas K, Hardegen NJ, Wahl LM, Hewlett IK, Clouse KA, Yamada KM, Dhawan S.

J Immunol. 2004 Dec 1;173(11):6735-44.

36.

Nucleotide sequence analysis of the accessory genes of HIV-1 group O isolates.

Vallejo A, Gurtler L, Zekeng L, Hewlett IK.

Virus Res. 2003 Feb;91(2):189-93.

PMID:
12573497
37.

Involvement of integrin alphavbeta3 in the pathogenesis of human immunodeficiency virus type 1 infection in monocytes.

Lafrenie RM, Lee SF, Hewlett IK, Yamada KM, Dhawan S.

Virology. 2002 May 25;297(1):31-8.

38.

The FDA approach to standardization and quality assurance of nucleic acid tests used to screen blood and plasma donations.

Epstein JS, Hewlett IK.

Dev Biol (Basel). 2000;102:223-7. Review. No abstract available.

PMID:
10794110
39.

HIV-1 infects and alters immune function of a monocyte subset expressing low CD14 surface phenotype.

Hardegen NJ, Toro LA, Muller J, Wahl LM, Hewlett IK, Dhawan S.

Viral Immunol. 2000;13(1):19-26.

PMID:
10733165
40.

Absence of human T-lymphotropic virus type I tax sequences in a population of normal blood donors in the Baltimore, MD/Washington, DC, area: results from a multicenter study.

Cowan EP, Nemo GJ, Williams AE, Alexander RK, Vallejo A, Hewlett IK, Lal RB, Dezzutti CS, Gallahan D, George K, Pancake BA, Zucker-Franklin D, McCurdy PR, Tabor E.

Transfusion. 1999 Aug;39(8):904-9.

PMID:
10504129
41.

Cutting edge: a short polypeptide domain of HIV-1-Tat protein mediates pathogenesis.

Boykins RA, Mahieux R, Shankavaram UT, Gho YS, Lee SF, Hewlett IK, Wahl LM, Kleinman HK, Brady JN, Yamada KM, Dhawan S.

J Immunol. 1999 Jul 1;163(1):15-20.

42.

V3-loop and nef gene sequences of HIV-1 isolates from a hemophiliac cohort with long-term non-progressive infection.

Vallejo A, Mas A, Heredia A, Altisent C, Lorenzo I, Soriano V, Hewlett IK.

AIDS. 1999 Mar 11;13(4):532-4. No abstract available.

PMID:
10197389
43.

Interagency Genome Amplification Testing Task Force: preliminary report.

McCullough J, Bianco C, Busch M, Dodd R, Hewlett IK, Jackson JB, Katz LM, McFarland J, Mied PA, Page P, Preston MS, Simon T, Stramer S, Stroncek D, Young CT.

Transfusion. 1998 Oct;38(10):903-4. No abstract available.

PMID:
9767738
44.

Tropism, coreceptor use, and phylogenetic analysis of both the V3 loop and the protease gene of three novel HIV-1 group O isolates.

Vallejo A, Heredia A, Mas A, Lee SF, Epstein JS, Soriano V, Hewlett IK.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15;18(5):417-25.

PMID:
9715837
45.

Phylogenetic analysis of HIV type 2 strains from Portugal.

Heredia A, Vallejo A, Soriano V, Silva A, Mansinho K, Fevereiro S, Mas A, Gutierrez M, Epstein JS, Hewlett IK.

AIDS Res Hum Retroviruses. 1998 Apr 10;14(6):471-3. No abstract available.

PMID:
9566548
46.

Genetic analysis of human immunodeficiency virus type 2 strains from Spain.

Heredia A, Vallejo A, Soriano V, Aguilera A, Caballero E, Epstein JS, Hewlett IK.

AIDS Res Hum Retroviruses. 1998 Jan 1;14(1):91-4. No abstract available.

PMID:
9453256
47.

Chemokine receptors and HIV-2.

Heredia A, Vallejo A, Soriano V, Epstein JS, Hewlett IK.

AIDS. 1997 Jul 15;11(9):1198-9. No abstract available.

PMID:
9233477
48.

Genetic analysis of an HIV type 2 subtype B virus from a Spanish individual with AIDS.

Heredia A, Vallejo A, Soriano V, Aguilera A, Mas A, Epstein JS, Hewlett IK.

AIDS Res Hum Retroviruses. 1997 Jul 1;13(10):899-900. No abstract available.

PMID:
9197384
49.

Evidence of HIV-2 infection in Equatorial Guinea (central Africa): partial genetic analysis of a B subtype virus.

Heredia A, Vallejo A, Soriano V, Gutierrez M, Puente S, Epstein JS, Hewlett IK.

AIDS Res Hum Retroviruses. 1997 Mar 20;13(5):439-40.

PMID:
9075486
50.

Food and Drug Administration conference on the feasibility of genetic technology to close the HIV window in donor screening.

Hewlett IK, Epstein JS.

Transfusion. 1997 Mar;37(3):346-51. No abstract available.

PMID:
9122911

Supplemental Content

Loading ...
Support Center